Daniel A Scott

7PUBLICATIONS
24CO-AUTHORS
Psychosocial aspects of childbirth and perinatal mental healthInfant and child healthInnate immunityPacific Peoples cultural determinants of healthPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 22, 2026
Phase 2 Randomized Bivalent RSVpreF Maternal Vaccine Trial: Final Safety, Antibody Persistence and Efficacy.

|Jul 21, 2025
Dynamics of Respiratory Syncytial Virus Illness and Serology During Pregnancy and Infancy in the United States and South Africa.

Shabir A Madhi, Eric A F Simões, Nicola P Klein

|Nov 11, 2022
Immunogenicity of a 20-valent pneumococcal conjugate vaccine in adults 18 to 64 years old with medical conditions and other factors that increase risk of pneumococcal disease.

Charu Sabharwal, Vani Sundaraiyer, Yahong Peng

|Mar 04, 2021
A randomized phase 1/2 study of the safety and immunogenicity of a multivalent pneumococcal conjugate vaccine in healthy adults 50 through 85 years of age.

Brandon Essink, James Peterson, Kari Yacisin

|Feb 05, 2021
A randomized phase 1 study of the safety and immunogenicity of 2 novel pneumococcal conjugate vaccines in healthy Japanese adults in the United States.

David Fitz-Patrick, Mariano Young, Daniel A Scott

|Jun 13, 2020
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence.

Erica Chilson, Daniel A Scott, Beate Schmoele-Thoma

Pageof 2

Frequent Collaborators

2 joint publications

Beate Schmöle-Thoma

2 joint publications

William C Gruber

1 joint publications

Thomas Verstraeten

1 joint publications

Mark A Fletcher